ViiV Healthcare, collectively owned by GlaxoSmithKline plc, Pfizer Inc., and Shionogi announced the approval of the U.S. Food and Drug Administration (FDA) for Cabotegravir, an antiviral drug.
Danaher Corporation announced the acquisition of Aldevron, to expand Danaher's life sciences segment.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3936
Published Date: May 30, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The increasing prevalence of chronic and acute diseases is anticipated to be major growth drivers of the market.
The market size of diagnostic cartridge field diagnostic system is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2023-2035.
The challenge of slower penetration due to challenges of quality control and result reporting are estimated to be the growth hindering factors for the market expansion.
The market in the APAC region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
The major players in the market are Siemens Healthineers AG, F. Hoffmann-La Roche AG, Danaher Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Arkray Inc., Becton, Dickinson and Company, Binx Health Limited, and others.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by type, end-user and by region.
The cardiac markers testing segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.